Chronic kidney disease-mineral and bone disorder has been associated with increasing morbid-mortality. The aim of this study was to determine the prevalence and phenotype of bone disease before transplantation and to correlate FGF23 and sclerostin levels with bone histomorphometry, and study possible associations between FGF23, sclerostin, and bone histomorphometry with cardiovascular disease and mortality. We performed a cross-sectional cohort study of a sample of 84 patients submitted to renal transplant, which were prospectively followed for 12 months. Demographic, clinical, and echocardiographic data were collected, laboratory evaluation, bone biopsy, and X-ray of the pelvis and hands were performed. Patient and graft survival were recorded. We diagnosed low bone turnover in 16 patients (19.5%); high bone turnover in 22 patients (26.8%); osteomalacia in 1 patient (1.2%), and mixed renal osteodystrophy in 3 patients (3.7%). At the end of 12 months, 5 patients had graft failure (5.9%), 4 had a cardiovascular event (4.8%), and 4 died. Age was associated with low remodeling disease, whereas high BALP and phosphorus and low sclerostin with high turnover disease. Sclerostin was a risk factor for isolated low bone volume. High BALP, low phosphorus, and low FGF23 were risk factors for abnormal mineralization. FGF23 appears as an independent factor for severity of vascular calcifications and for cardiovascular events, whereas the presence of valve calcifications was associated with low volume and with turnover deviations. Sclerostin was associated a higher HR for death. Sclerostin and FGF23 seemed to provide higher cardiovascular risk, as well as low bone volume, which associated with extra-osseous calcifications.
Ferreira, Ana Carina, Cotovio, Patrícia, Aires, Inês et al. The Role of Bone Volume, FGF23 and Sclerostin in Calcifications and Mortality; a Cohort Study in CKD Stage 5 Patients. // Calcified Tissue International. – 2022. – DOI: 10.1007/s00223-021-00910-8. – URL: http://link.springer.com/openurl/fulltext?id=doi:10.1007/s00223-021-00910-8
Ferreira, Ana Carina, Cotovio, Patrícia, Aires, Inês, Mendes, Marco, Navarro, David, Silva, Cecília, Caeiro, Fernando, Salvador, Rute, Correia, Bruna, Cabral, Guadalupe, Nolasco, Fernando, Ferreira, & Aníbal (2022). The Role of Bone Volume, FGF23 and Sclerostin in Calcifications and Mortality; a Cohort Study in CKD Stage 5 Patients. Calcified Tissue International. https://doi.org/10.1007/s00223-021-00910-8
Ferreira, et al. “The Role of Bone Volume, FGF23 and Sclerostin in Calcifications and Mortality; a Cohort Study in CKD Stage 5 Patients.” Calcified Tissue International, 2022. doi:10.1007/s00223-021-00910-8.
@article{Ferreira2022,
title = {The Role of Bone Volume, FGF23 and Sclerostin in Calcifications and Mortality; a Cohort Study in CKD Stage 5 Patients},
author = {Ferreira and Carina, Ana and Cotovio and Patrícia and Aires and Inês and Mendes and Marco and Navarro and David and Silva and Cecília and Caeiro and Fernando and Salvador and Rute and Correia and Bruna and Cabral and Guadalupe and Nolasco and Fernando and Ferreira and Aníbal},
journal = {Calcified Tissue International},
year = {2022},
doi = {10.1007/s00223-021-00910-8},
url = {http://link.springer.com/openurl/fulltext?id=doi:10.1007/s00223-021-00910-8}
}
The human microbiota functions at the interface between diet, medication-use, lifestyle, host immune development and health. It is therefore closely aligned with many of the recognised modifiable factors that influence bone mass accrual...
Mazabraud’s syndrome (MZB) is a rare condition in which fibrous dysplasia of bone/the McCune-Albright syndrome (FD/MAS) co-exists with intramuscular myxomas. Both FD and the myxomas harbor the GNAS- mutation. Recent studies have shown...
Trans-sutural distraction osteogenesis has been proposed as an alternative technique of craniofacial remodelling surgery for craniosynostosis correction. Many studies have defined the contribution of a series of biological events to...
Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia type 1 (MED1) are two rare skeletal disorders caused by cartilage oligomeric matrix protein ( COMP ) variants. This study aims to analyze the genotype and phenotype of...
Patients with Osteogenesis Imperfecta (OI) present extra-skeletal manifestations, including important orodental and craniofacial features as dentinogenesis imperfecta, dental agenesis, failure of maxilla growth and hypotonia of...